ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1368	National Cancer Institute	Html	en	Breast Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for breast cancer.	Breast Screening Study-2 0.614803 breast cancer deaths 0.621624 widespread mammography screening 0.607903 biennial screening mammography 0.591767 breast cancer case 0.582361 Mammography screening rates 0.59827 meaningful breast cancer 0.581856 breast biopsy 0.585064 Breast Screening Study 0.610161 digital mammography 0.665528 breast screening 0.639247 mammography 0.707944 film mammography 0.596868 Canadian National Breast 0.584048 Nijmegen breast cancer 0.583392 breast cancer treatment 0.611216 Natl Cancer Inst 0.587118 mammography service screening 0.585616 reduces breast cancer 0.583893 Breast Cancer Diagnosis 0.59888 breast cancer therapy 0.585682 invasive breast cancer 0.614887 breast tomosynthesis screening 0.597792 women 0.639036 National Breast Screening 0.627397	early breast cancer 0.585311 increases breast cancer 0.597473 breast cancer detection 0.615948 Breast Screening Program 0.60752 breast cancer die 0.596834 late-stage breast cancer 0.587879 significant breast cancer 0.583394 breast cancers 0.586001 Digital Screening Mammography 0.598927 mammography screening 0.623635 screening mammography 0.613991 Mammography Screening Effectiveness 0.588634 digital breast tomosynthesis 0.604618 UK breast screening 0.596293 breast cancer screening 0.748635 breast cancer risk 0.584885 reduced breast cancer 0.582941 breast cancer 0.993291 clinical breast examination 0.595498 breast cancer mortality 0.853194 breast cancer cases 0.601413 breast cancer mortality. 0.607032 full-field digital mammography 0.586893 breast cancer incidence 0.622797	CLICK HERE
1570	National Cancer Institute	Html	en	Neuroblastoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood neuroblastoma.	cancer treatment 0.566372 neuroblastoma 0.915175 tumor biology 0.626071 malignant tumor cells 0.558857 body 0.647664 chemotherapy 0.49696 PDQ cancer information 0.548139 clinical trials 0.793699 cancer information summary 0.51948 low-risk neuroblastoma 0.514243 clinical trial 0.659456 high-risk neuroblastoma 0.659347 tumor histology 0.510739 favorable tumor biology 0.542334 unfavorable tumor biology 0.522724 treatment clinical trial 0.493293 lymph nodes 0.501542 radiation therapy 0.646669 Treatment Editorial Board 0.49305 neuroblastoma spreads 0.512002 Neuroblastoma Treatment 0.537187 neuroblastoma cell 0.510315 treatment 0.836037 time neuroblastoma 0.52866 cancer cells 0.648207	recurrent neuroblastoma 0.571181 neuroblastoma talk 0.50906 Neuroendocrine tumor cells 0.542579 neuroblastoma cells 0.566453 treatment clinical trials 0.520878 National Cancer Institute 0.53108 tumor cells 0.633055 intermediate-risk neuroblastoma 0.542626 new treatment 0.533829 Progressive/Recurrent Neuroblastoma 0.502026 primary tumor 0.499207 metastatic tumor 0.511477 blood 0.501083 Iodine 131-MIBG therapy 0.54351 bone marrow 0.53977 stage 4S neuroblastoma 0.523743 cancer clinical trials 0.49476 Recurrent CNS Neuroblastoma 0.519837 stem cell rescue 0.505173 tumor 0.835165 treatment options 0.506317 cancer 0.929691 standard treatment 0.535537 metastatic neuroblastoma 0.513574	CLICK HERE
1663	National Cancer Institute	Html	en	Childhood Astrocytomas Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood astrocytomas.	cancer treatment 0.624127 new cancer cells 0.50571 high-grade astrocytoma 0.568902 star-shaped brain cells 0.50361 metastatic brain tumors 0.515525 type 0.567046 tuberous sclerosis 0.508341 chemotherapy 0.51254 proton beam radiation 0.504515 PDQ cancer information 0.568694 clinical trial search 0.544652 brain tumors 0.664824 children 0.509721 new blood vessels 0.577461 dead tumor cells 0.517027 clinical trials 0.906249 cancer information summary 0.537035 clinical trial 0.760659 stem cell transplant 0.512502 treatment clinical trial 0.503103 radiation therapy 0.993729 Treatment Editorial Board 0.497213 beam radiation therapy 0.519746 subependymal giant cell 0.530817	treatment 0.904348 general information 0.532617 cancer cells 0.898737 conformal radiation therapy 0.568043 intensity-modulated radiation therapy 0.52166 specific cancer cells 0.501338 stereotactic radiation therapy 0.544315 childhood high-grade astrocytoma 0.500502 astrocytoma 0.619975 low-grade astrocytoma 0.590271 treatment clinical trials 0.531572 National Cancer Institute 0.535683 spinal cord 0.789593 effects cancer treatment 0.512031 new treatment 0.578461 external radiation therapy 0.577741 brain 0.729014 childhood astrocytoma 0.499108 cancer clinical trials 0.564469 checks tumor tissue 0.501876 tumor 0.802924 cancer 0.956922 information 0.571652 childhood low-grade astrocytoma 0.521596	CLICK HERE
1888	National Cancer Institute	Html	es	Tratamiento del linfoma de Hodgkin en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin en adultos.	siguientes procedimientos 0.457132 células madre 0.773484 sedimentación globular vsg 0.343223 estadio iv 0.386067 siguientes elementos 0.335371 sudores nocturnos 0.52867 Elabora glóbulos 0.342317 siguientes afecciones 0.326701 siguientes especialistas 0.324883 siguientes tipos 0.334479 área cercanos.ampliar linfoma 0.414688 rayos x 0.318853 Hodgkin Lymphoma 0.444389 abdomen).ampliar linfoma 0.405698 enlace drugs approved 0.376199 largo plazo 0.313634 malformaciones congénitas 0.344911 escáner tep 0.32264 ondas sonoras 0.318768 estadio ie 0.448154 efectos tardíos 0.386184 cáncer.ampliar aspiración 0.320544	quimioterapia sistémica 0.399855 National Cancer Institute 0.315084 siguientes riesgos 0.314848 Instituto Nacional 0.326237 PDQ Tratamiento 0.422426 estadio iie 0.390253 líquido incoloro 0.32327 Herpes zóster 0.316049 estadio iiie 0.444346 siguientes problemas 0.333894 estadio e 0.345757 siguientes factores 0.326864 Physician Data Query 0.353006 siguientes subtipos 0.336371 siguientes sitios 0.33013 Leucemia mielógena aguda 0.327537 hodgkin clásico.ampliar célula 0.434672 estadio iiis 0.943901 células formadoras 0.331979 almacena glóbulos 0.343421 siguientes sumarios 0.346893 siguientes pruebas 0.333482	CLICK HERE
1972	National Cancer Institute	Html	es	Tratamiento del sarcoma de Kaposi (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del sarcoma de Kaposi.	PDQ Tratamiento 0.421281 estadios tardíos 0.422639 siguientes procedimientos 0.46906 linfocitos cd34 0.430375 Physician Data Query 0.440927 pequeña cantidad 0.415736 Estados Unidos 0.462912 Kaposi causa efectos 0.710153 siguientes tipos 0.434075 vía oral 0.416125 rayos x 0.425639 Kaposi africano 0.971754	enlace drugs approved 0.48088 células cd34 0.490481 siguientes formas 0.418075 vías respiratorias 0.427366 Kaposi Sarcoma 0.792161 estudio clínico 0.421218 National Cancer Institute 0.409422 terapia tarc 0.47747 siguientes riesgos 0.407053 siguientes pruebas 0.484334 Instituto Nacional 0.419362	CLICK HERE
3430	National Cancer Institute	Html	es	Vitamina D y prevención del cáncer	Hoja informativa que resume los resultados de estudios sobre la vitamina D y la prevención del cáncer. Incluye información acerca de las recomendaciones dietéticas de vitamina D.	or without calcium 0.304559 pre-diagnostic circulating 0.302687 Nomura AM 0.302611 menor incidencia 0.30287 Bueno-de-Mesquita HB 0.302697 Sin embargo 0.347217 vitamina d2 0.359138 vitamina d 0.969991 Working Group Reports 0.305032 Nutrition Examination Survey 0.305408 Dietary Reference Intakes 0.304573 Preventive Services Task 0.304306 Kotchen JM 0.302687 Instituto Nacional 0.302694 Jenab M 0.302565 IARC Working Group 0.325138 estudio vitamin 0.304251 Internal Medicine 0.302749 nested case-control study 0.304876 Calcium plus 0.302727 vitamina d3 0.358882 rayos ultravioleta 0.302804 Academias Nacionales 0.302714 PubMed Abstract 0.415835 omega-3 trial 0.309613	updated meta-analysis 0.302703 Clinical Oncology 0.303267 International Journal 0.302591 cohort study 0.30307 vitamin d 0.319766 Contemporary Clinical Trials 0.305104 Endocrine-Related Cancer 0.30602 Numerosos estudios 0.304406 luz solar 0.307463 alto consumo 0.305055 primary prevention 0.303006 large randomized controlled 0.30456 siguientes consumos 0.303025 Yetley EA 0.302569 Woolcott CG 0.302657 Clinical Nutrition 0.303564 consumos dietéticos promedio 0.306519 systematic review 0.302703 Larriba MJ 0.302545 Women’s Health Initiative 0.30465 Wilkens LR 0.302784 suficiente vitamina d 0.340884 New England Journal 0.304545 Brulé D 0.306623	CLICK HERE
15637	National Cancer Institute	Html	null	Research Funding Mechanisms	The NCI uses grants, cooperative agreements, and contracts to help stimulate and fund cancer research.			CLICK HERE
16651	National Cancer Institute	Html	en	Current and Alumni Fellows	NCI and FDA collaborate to train scientists in research and research-related regulatory review. Meet the current IOTF fellows.	different manufacturing methods 0.665313 product quality research/review 0.827177 hematopoietic stem cell 0.710973 cancer signal transduction 0.668322 Doctoral degree 0.684206 product quality 0.918183 challenging supervisory roles 0.648276 Oncology Task Force 0.8356 oncology drug products 0.690726 long term goal 0.660419 Review Team Leader 0.655657 Biological Sciences 0.682061 gene therapy products 0.670826 new therapeutic targets 0.828038 DNA repair proteins 0.657265 Dr. Sanduja 0.871474 overall research 0.68067 invaluable training experience 0.676806 NCI-FDA Interagency Oncology 0.711009 oncology product research 0.767652 drug development process 0.675006 cell therapy products 0.686143 experienced product quality 0.672111 Mixed Lineage Leukemia 0.669398 intramural FDA training/courses 0.684636	various FDA centers 0.683563 regulatory sciences 0.680019 NCI-NIH-FDA Interagency Oncology 0.692697 post-doctoral training 0.683105 mesenchymal stromal cells 0.685647 breast cancer metastasis 0.669833 product quality reviewer 0.814583 South Carolina 0.648309 IOTF fellowship 0.939794 current fellows 0.684819 acute myeloid leukemia 0.671421 Task Force Fellowship 0.822403 full-time product quality 0.810197 oncology research experience 0.714771 National Cancer Institute 0.698441 cancer stem cells 0.955681 Interagency Oncology Task 0.843679 mammary stem cell 0.68776 quality research/review fellow 0.82871 breast cancer stem 0.695251 Dr. Ergen 0.910594 Jawaharlal Nehru University 0.669149 pre-clinical cancer models 0.702445 national regulatory conferences 0.67238	CLICK HERE
16716	National Cancer Institute	Html	en	NCI Cancer Moonshot℠ Public Access and Data Sharing Policy	NCI has established a data sharing policy that supports open, public access to all research and data for projects funded as part of the Cancer Moonshot. Find details on the policy.	Underlying Primary Data 0.835591 National Cancer Advisory 0.204571 Creative Commons 0.266314 Cancer Moonshotâ„  0.229846 Moonshot Research Project 0.326921 public domain tool 0.238273 extramural Cancer Moonshot 0.217832 Cancer Moonshot beginning 0.210573 cancer research 0.226051 Data Sharing Repositories 0.219342 underlying data 0.223365 NIH Sharing Policies 0.206938 Genomic Data Sharing 0.238331 Moonshot Research Projects 0.712789 Cancer Moonshotâ„  Research 0.221203 NIH Data Sharing 0.283755 National Cancer Institute 0.205263 Cancer Moonshot Projects 0.211704 public access 0.827988	Blue Ribbon Panel 0.23172 Cancer Moonshot Research 0.963477 independent data access 0.222133 data sharing policies 0.240205 Public Access Policy. 0.214656 nih public access 0.329101 Genomic Data Commons 0.208284 Enhanced Data Sharing 0.250631 Public Access Policy 0.237717 NCI-Supported Cancer Moonshot 0.379658 appropriate Public Access 0.254192 cancer research projects 0.217712 NCI researchers 0.205129 NCI intramural Cancer 0.231006 Data Sharing Policy 0.330676 Rule.7 Underlying Primary 0.217644 Data Sharing Plan 0.965755 intramural Cancer Moonshot 0.258314 Cancer Moonshot Public 0.244424	CLICK HERE
17234	National Cancer Institute	Html	en	Adding Immune-based Treatments to Standard Glioblastoma Therapy	This clinical trial is testing standard therapy (surgery, radiation and temozolomide) plus immunotherapy with pembrolizumab with or without a cancer treatment vaccine for patients with newly diagnosed glioblastoma, a common and deadly type of brain tumor.	immune checkpoint inhibitor 0.991382 Dr. Gilbert 0.728039 tumor tissue 0.405841 trial contact information 0.29929 experimental vaccine 0.247456 1-year overall survival 0.300393 NCI’s Cancer 0.233291 Treating Patients 0.208707 little tumor tissue 0.376059 standard therapy plus 0.329661 immune response 0.550076 NCI Clinical Trials 0.330246 chemotherapy drug temozolomide 0.399109 cancer treatment vaccine 0.66133 primary brain tumor 0.428278 Cancer Research 0.215559 clinical trials 0.480839	slow tumor growth 0.416918 partially randomized phase 0.30891 patients 0.251176 Mark R. Gilbert 0.399405 tumor-specific vaccine 0.249165 experimental cancer treatment 0.582716 immune checkpoint inhibitors 0.542772 microscopic tumor 0.266367 newly diagnosed glioblastoma 0.842005 Current standard therapy 0.36143 placebo vaccine 0.253985 immunotherapy drug pembrolizumab 0.351275 median survival time 0.347591 protocol summary 0.359999 radiation therapy 0.342013 standard therapy 0.747186	CLICK HERE